Real-World Insulin Treatment Persistence among Patients with Type 2 Diabetes
Author:
Publisher
Elsevier BV
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Link
http://aace.metapress.com/index/QJ6U336873K63337.pdf
Reference38 articles.
1. Economic impact of antidiabetic medications and glycemic control on managed care organizations: a review of the literature;Stephens;J Manag Care Pharm.,2006
2. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus;Ho;Arch Intern Med.,2006
3. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes;Pladevall;Diabetes Care.,2004
4. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review;Lee;Manag Care Interface.,2006
5. Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper;Breitscheidel;J Med Econ.,2010
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa;Endocrine Reviews;2024-01-16
2. Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100);Clinical Diabetes;2023-03-28
3. Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes;Diabetes Therapy;2023-02-27
4. Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-10
5. Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin;Journal of Managed Care & Specialty Pharmacy;2022-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3